These data suggested that embelin downregulating cFLIPL could enhance TRAIL sensitivity of breast cancer cells and the soluble TRAIL secretion by hUCMSCs could effectively increase the apoptosis of breast cancer cells. The gene discussed is CFLAR; the disease is breast carcinoma.